Pulmonary cryptococcosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years, gender unrestricted; 2.Clinically suspected pulmonary cryptococcosis (such as pulmonary nodules, infiltrative shadows with respiratory symptoms); 3.Agree to participate in this study and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. HIV-infected patients 2. With severe systemic diseases (such as terminal tumors, severe heart failure, liver and kidney failure, etc.) 3. Participating in other interventional clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnosis result;Therapeutic response;Clinical outcome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events in the study;Related complications; | — |
Countries
China
Contacts
Ninghai First Hospital